HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection.

Abstract
Acute hemorrhagic conjunctivitis due to enterovirus 70 has caused extensive outbreaks in tropical areas since 1969. Between December 1, 1990, and March 4, 1991, an outbreak of acute hemorrhagic conjunctivitis due to enterovirus 70 occurred in American Samoa, where an outbreak due to the same agent had occurred in 1981. A survey of 5% of the households (134 households, 1,095 individuals) was conducted throughout the island of Tutuila. The outbreak affected 58% of the population, with age-specific attack rates greater than 50% for all age groups except children younger than 2 years. Attack rates were significantly higher for children 2-10 years old (65%) than in the remainder of the population. Women aged 21-40 years had higher rates than did men the same age (66 vs. 49%), possibly because of the close association of women and young children. At higher preepidemic titers, there was evidence of protection from clinical disease among males but not among females. Enterovirus 70 can cause large outbreaks even in a population already exposed in a previous large outbreak; protection due to previous infection is only partial.
AuthorsC Bern, M A Pallansch, H E Gary Jr, J P Alexander, T J Török, R I Glass, L J Anderson
JournalAmerican journal of epidemiology (Am J Epidemiol) Vol. 136 Issue 12 Pg. 1502-6 (Dec 15 1992) ISSN: 0002-9262 [Print] United States
PMID1337662 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
Topics
  • Antibodies, Bacterial (blood)
  • Conjunctivitis, Acute Hemorrhagic (epidemiology, immunology, microbiology)
  • Disease Outbreaks
  • Enterovirus
  • Enterovirus Infections (epidemiology, immunology)
  • Female
  • Humans
  • Independent State of Samoa (epidemiology)
  • Male
  • Neutralization Tests
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: